Skip to main content
Log in

Association between resistin gene −420 C/G polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis

  • Short Communication
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Epidemiological studies on the association between the single nucleotide polymorphism (SNP) at −420 C/G (rs1862513) in the human resistin gene (RETN) and the risk of type 2 diabetes mellitus (T2DM) are conflicting. In order to derive a more precise estimation of the association, a meta-analysis was conducted. Twelve studies with 5,935 cases and 5,959 controls were enrolled by searching the databases of Medline, EMBASE, and Cochrane. Summary odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. The heterogeneity and publication bias were investigated. The main analysis indicated no significant association [for allelic model: OR = 0.97 (0.92–1.03); for additive model: OR = 0.95 (0.83–1.09); for recessive model: OR = 0.98 (0.86–1.12); for dominant model: OR = 0.95 (0.88–1.04)]. Overall, no significant heterogeneity was found. Subgroup analysis by race and source of controls indicated no significant association. In conclusion, the current meta-analysis did not observe any association between the polymorphism of RETN −420 C/G and the risk of T2DM. The study may help us further understand the genetics of T2DM. However, larger and prospective studies are warranted to confirm this finding.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Abbreviations

BNP:

Brain natriuretic peptide

CI:

Confidence interval

OR:

Odds ratio

RETN:

Resistin gene

T2DM:

Type 2 diabetes mellitus

References

  1. Zimmet P (2000) Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted? J Intern Med 247(3):301–310

    Article  PubMed  CAS  Google Scholar 

  2. Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414(6865):782–787

    Article  PubMed  CAS  Google Scholar 

  3. De Fronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM a balanced overview. Diabetes Care 15(3):318–368

    Article  Google Scholar 

  4. Choquet H, Cavalcanti-Proenca C, Lecoeur C et al (2009) The T-381C SNP in BNP gene may be modestly associated with type 2 diabetes: an updated meta-analysis in 49 279 subjects. Hum Mol Genet 18(13):2495–2501

    Article  PubMed  CAS  Google Scholar 

  5. Gouda HN, Sagoo GS, Harding AH et al (2010) The association between the peroxisome proliferator receptor-γ2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis. Am J Epidemiol 171(6):645–655

    Article  PubMed  Google Scholar 

  6. McGarthy MI, Zeggini E (2009) Genome-wide association studies in type 2 diabetes. Curr Diab Rep 9(2):164–171

    Article  Google Scholar 

  7. Voight BF, Scott LJ, Steinthorsdottir V et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42(7):579–589

    Article  PubMed  CAS  Google Scholar 

  8. Holcomb IN, Kabakoff RC, Chan B et al (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19(15):4046–4055

    Article  PubMed  CAS  Google Scholar 

  9. McTernan PG, Kusminski CM, Kumar S (2006) Resistin. Curr Opin Lipidol 17(2):170–175

    Article  PubMed  CAS  Google Scholar 

  10. Steppan CM, Bailey ST, Bhat S et al (2001) The hormone resistin links obesity to diabetes. Nature 409(6818):307–312

    Article  PubMed  CAS  Google Scholar 

  11. Norata GD, Ongari M, Garlaschelli K et al (2007) Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 156(2):279–284

    Article  PubMed  CAS  Google Scholar 

  12. Osawa H, Tabara Y, Kawamoto R et al (2007) Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care 30(6):1501–1506

    Article  PubMed  CAS  Google Scholar 

  13. Hivert MF, Sullivan LM, Fox CS et al (2008) Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 93(8):3165–3172

    Article  PubMed  CAS  Google Scholar 

  14. Menzaghi C, Coco A, Salvemini L et al (2006) Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. J Clin Endocrinol Metab 91(7):2792–2795

    Article  PubMed  CAS  Google Scholar 

  15. Hivert MF, Manning AK, McAteer JB et al (2009) Association of variants in RETN with plasma resistin levels and diabetes-related traits in the framingham offspring study. Diabetes 58(3):750–756

    Article  PubMed  CAS  Google Scholar 

  16. Osawa H, Yamada K, Onuma H et al (2004) The G/G genotype of a resistin single-nucleotide polymorphism at −420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet 75(4):678–686

    Article  PubMed  CAS  Google Scholar 

  17. Emamgholipour S, Hossein-nezhad A, Najmafshar A et al (2009) Promoter resistin gene polymorphism in patients with type 2 diabetes and its influence on concerned metabolic phenotypes. Iran J Diabetes Lipid Disord 8:150–156

    Google Scholar 

  18. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820–823

    Article  PubMed  CAS  Google Scholar 

  19. Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560

    Article  PubMed  Google Scholar 

  20. Eggert M, Davey SG, Schneider M et al. (91997) Bias in meta-analysis detected by a simple graphical test. BMJ 315(7109):629–634

    Google Scholar 

  21. Engert JC, Vohl MC, Williams SM et al (2002) 5′ flanking variants of resistin are associated with obesity. Diabetes 51(5):1629–1634

    Article  PubMed  CAS  Google Scholar 

  22. Ma X, Warram JH, Trischitta V et al (2002) Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87(9):4407–4410

    Article  PubMed  CAS  Google Scholar 

  23. Cho YM, Youn BS, Chung SS et al (2004) Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 47(3):559–565

    Article  PubMed  CAS  Google Scholar 

  24. Cho YM, Ritchie MD, Moore JH et al (2004) Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus. Diabetologia 47(3):549–554

    Article  PubMed  CAS  Google Scholar 

  25. Bouchard L, Weisnagel SJ, Engert JC et al (2004) Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Quebec Family Study. J Endocrinol Invest 27(11):1003–1009

    PubMed  CAS  Google Scholar 

  26. Conneely KN, Silander K, Scott LJ et al (2004) Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 47(10):1782–1788

    Article  PubMed  CAS  Google Scholar 

  27. Osawa H, Onuma H, Ochi M et al (2005) Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem Biophys Res Commun 335(2):596–602

    Article  PubMed  CAS  Google Scholar 

  28. Kunnari A, Ukkola O, Kesäniemi YA (2005) Resistin polymorphisms are associated with cerebrovascular disease in finnish type 2 diabetic patients. Diabet Med 22(5):583–589

    Article  PubMed  CAS  Google Scholar 

  29. Ochi M, Osawa H, Hirota Y et al (2007) Frequency of the G/G genotype of resistin single nucleotide polymorphism at −420 appears to be increased in younger-onset type 2 diabetes. Diabetes 56(11):2834–2838

    Article  PubMed  CAS  Google Scholar 

  30. Suriyaprom K, Phonrat B, Namjuntra P et al (2009) The +299(G > A) resistin gene polymorphism and susceptibility to type 2 diabetes in Thais. J Clin Biochem Nutr 44(1):104–110

    Article  PubMed  CAS  Google Scholar 

  31. Tsukahara T, Nakashima E, Watarai A et al (2009) Polymorphism in resistin promoter region at −420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients. Diabetes Res Clin Pract 84(2):179–186

    Article  PubMed  CAS  Google Scholar 

  32. Chi S, Lan C, Zhang S et al (2009) Association of −394C > G and −420C > G polymorphisms in the RETN gene with T2DM and CHD and a new potential SNP might be exist in exon 3 of RETN gene in Chinese. Mol Cell Biochem 330(1–2):31–38

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Science Foundation of China (No. 30771805).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ying Wen.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 41 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wen, Y., Lu, P. & Dai, L. Association between resistin gene −420 C/G polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis. Acta Diabetol 50, 267–272 (2013). https://doi.org/10.1007/s00592-010-0247-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-010-0247-8

Keywords

Navigation